“…Codeine [10,15,16,27,44,48,59] Dextropropoxyphene [27,48,52] Dihydrocodeine [37,59] Oxycodone [44,48] Propoxyphene The studies had either short [41] or variable follow-up periods [15,17,48]. The reasons for termination of the survey were death [16,17,26,27,29,38,42,48,54,59], freedom from pain [15,29,42,59], low compliance [15,27,29,42], treatment continued by practitioner or in another hospital [15,16,29,42,59], loss of follow-up or contact (drop out) [13,15,16,27,29,38,42,54,59], n...…”